Modern Healthcare Mobile


Home | Current Issue | Newsmakers
IMS Health acquires social-media analytics firm Semantelli

By Joseph Conn
Posted: May 2, 2013 - 2:15 pm ET

Prescription drug data-miner IMS Health, Danbury, Conn., is adding social media content analysis to its repertoire, having announced the acquisition of Semantelli Corp., a social-media analytics company based in a Bridgewater, N.J.

Terms of the deal were undisclosed.

“Semantelli offers clients a robust set of cloud-based tools that automate the collection of healthcare-specific social media content, providing real-time monitoring for reputation and opportunity management and delivering insights into consumer and physician behavior and sentiments,” according to an IMS Health news release.

Semantelli's technologies, it said, “enable organizations to access, navigate and analyze both structured and unstructured data from thousands of online resources, including popular social networks and other social media platforms.” Its taxonomies, algorithms, “named-entity recognition,” natural-language processing and machine-learning capabilities support more than 50 languages “to detect trends in disease areas and treatments.”

“Social media has become an integral part of the healthcare experiences, and navigating this channel effectively to unlock the right information for making decisions is critical,” said Stefan Linn, senior vice president for strategy and global pharmaceutical solutions for IMS Health, in the news release.

IMS Health draws data from “nearly 100,000 suppliers” on 39 billion healthcare transactions, providing services to clients in government and the pharma, biotech, medical device, medical research and health insurance industries, it said.

In March, IMS Health acquired Appature, a market adviser to the pharmaceutical, medical device and consumer healthcare industries.

Last summer, Vermont was ordered by a federal court to pay IMS Health $2.4 million for its legal fees in fighting a Vermont law that sought to limit the use of prescription drug data for marketing to physicians. The 2007 law was struck down in 2011 by the U.S. Supreme Court in a controversial decision taking down with it similar laws in Maine and Vermont.

Follow Joseph Conn on Twitter: @MHJConn



| Home | Feedback |
 

© Modern Healthcare | All rights reserved | Privacy Statement | Terms of Use